1. Kovalenko VN, Kornatsky VM, editors. [Problems of health and life expectancy in modern conditions (manual)]. Kyiv: Drukarnya «Gordon»; 2017. 299 p. Ukrainian.
2. Wilkins E, Wilson L, Wickramasinghe K, Bhatnagar P, Leal J, Luengo-Fernandez R, et al. European cardiovascular disease statistics 2017. Brussels: European Heart Network; 2017. 192 p.
3. Mit’kovskaya NP. [Cardiology and comorbidity. In: I International Congress of Cardiologists and Therapists: Collection of scientific papers; 2016 May 12-13; Minsk. Minsk: Capital Print; 2016. p. 173-7. Russian.
4. David LA, Grosu AA, Raducan AM, Kuzor TS. [Cardiovascular mortality and the risk of sudden death in the post-infarction period are higher in patients with diabetes mellitus]. Eurasian Cardiology Journal. 2016;(3):159-60. Russian.
5. Ametov AS, Lysenko MA. [Type 2 diabetes mellitus and cardiovascular diseases as a clash of two global noncommunicable epidemics]. International Endocrinology Journal. 2011;(7):56-9. Russian.
6. Chesnikova AI, Batyushin MM, Terentyev VP. [Arterial hypertension and comorbidity: the present state of the problem]. Arterial hypertension. 2016;22(5):432-40. Russian.
7. Yarmonenko SP, Weinson AA. [Radiobiology of humans and animals]. Moscow: Higher school; 2004. 549 p. Russian.
8. Kovalenko VN., Lutay MI, Sirenka YM, Sichova OS, editors. [Cardiovascular diseases. Classification, standards of diagnostics and treatment]. Kyiv: MORION; 2016. 192 p. Ukrainian.
9. Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, et al. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary. Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD). Diab Vasc Dis Res. 2014;11(3):133-73.
10. Porovsky YV, Tetenev FF. [Comorbidity in medical practice]. Siberian medical review. 2015;(4):5-10. Russian.